Urolon Companies
Rethinking stress incontinence treatment with Urolon®, an innovative bioresorbable urethral injectable as a first choice, minimally invasive treatment after pelvic floor muscle therapy. Urolon® bridges the gap between conservative and surgical interventions. CE certified since 2018, available in 12 countries.
Industry:
Pelvic & Uterine Healthcare
Headquarters:
Utrecht, The Netherlands
Founded Date:
2014
Employees Number:
10-1
Register and Claim Ownership